Revenue

A new iPSC-derived cell therapy from Unixell Biotech has gained FDA approval for clinical trials, offering a regenerative approach for millions with epilepsy.

Institutional Investor launches an allocator-curated 'Buy List' to benchmark private equity excellence, prioritizing transparency and governance over marketing.

Emerald Holding reports a 16% revenue jump but a $30.7M net loss, driven by acquisition costs, as the board considers a potential company sale.

Andreas Szakacs Productions unveils "Shadow Fist," an MMA drama built on a new financial model that could change how independent films get made.

At SXSW, Reckitt Catalyst and Serena Williams unveil a new cohort of U.S. entrepreneurs tackling America's deep-rooted healthcare access crisis.

The healthcare REIT's significant dividend increase is backed by a record year of investment, a strong balance sheet, and strategic expansion into new markets.

The German biotech firm secured its Nasdaq listing, but a near-total investor redemption leaves its cancer-drug pipeline with less than $1M in trust funds.

A landmark study reveals an accelerated brain stimulation protocol can treat major depression in six days, offering rapid relief and dismantling barriers to care.

A key player in the sustainable fuel supply chain announces a leadership transition, positioning itself to capitalize on the soaring demand for renewable energy.

China's BABI launches a 4-in-1 sunscreen using patented tech and Nobel-inspired science to solve irritation, feel, and protection gaps.

Celebrating its 50th anniversary, Barcelona's mega-show expects 110,000+ visitors, showcasing global food trends, AI, and sustainability.

Genenta's rebrand to Saentra Forge signals a major shift into Italian national security, as its CEO gains a key government-backed diplomatic post.

SpaceX acquires a key composite tech supplier from Hexagon Purus, a deal that fuels its Starship ambitions and lets the energy firm focus on its core mission.

A new tech-heavy vape launches in Africa, targeting youth with social apps and custom features, just as regulators and health officials declare war on vaping.

With a key regulatory approval, fintech firm QuantPower brings institutional-grade automated trading to everyday investors, signaling a shift in India's market.

The nation's largest beauty retailer is betting big on ingestible wellness, partnering with Cymbiotika to bring advanced supplements to over 1,000 stores.

The $759B nutrition market in Asia is no longer just about health. Consumers now demand emotional benefits, natural ingredients, and ultimate convenience.

An Australian firm's new modular smelter aims to unlock stranded iron ore value, promising lower-cost, clean steel and a manufacturing revival.

The grill maker's 1-for-50 reverse stock split aims to avoid delisting, but deep financial woes and historical data suggest a tough road ahead.

ROHM's new SiC modules are now on DigiKey, democratizing access to next-gen power tech for EVs and industry, challenging market leaders.